抑制STAT3信号减少IgA肾病中IgA1自身抗原产生
本研究探讨IL-6信号通路在IgA肾病中导致半乳糖缺陷型IgA1过度产生的机制。通过激酶活性谱分析和蛋白质印迹,发现患者IgA1分泌细胞中STAT3被IL-6差异化激活,磷酸化增强且延长,导致半乳糖缺陷型IgA1过度产生;JAK/STAT小分子抑制剂可阻断此过程。提示STAT3通路可能成为IgA肾病特异性治疗新靶点。
要点
- IgA肾病患者IgA1分泌细胞中IL-6诱导STAT3磷酸化增强且延长。
- STAT3异常激活导致半乳糖缺陷型IgA1过度产生。
- JAK/STAT小分子抑制剂可阻断IL-6介导的半乳糖缺陷型IgA1过度产生。
核心结论
- IL-6诱导的STAT3异常激活介导半乳糖缺陷型IgA1过度产生,STAT3信号通路可能成为IgA肾病疾病特异性治疗新靶点。
研究设计与样本
- 基础研究:分析IgA肾病患者与健康对照者IgA1分泌细胞中IL-6信号通路,采用激酶活性谱分析、蛋白质印迹、siRNA敲低和小分子抑制剂确认实验。
主要发现
- 与健康对照者相比,IgA肾病患者IgA1分泌细胞中STAT3被IL-6差异化激活。
- IL-6诱导患者细胞中STAT3磷酸化增强且延长,导致半乳糖缺陷型IgA1过度产生。
- JAK/STAT信号小分子抑制剂可阻断IL-6介导的半乳糖缺陷型IgA1过度产生。
临床怎么用
- STAT3信号通路可能作为IgA肾病疾病特异性治疗的潜在靶点,但尚无临床推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: IgA nephropathy is a chronic renal disease characterized by mesangial immunodeposits that contain autoantigen, which is aberrantly glycosylated IgA1 with some hinge-region O-glycans deficient in galactose. Macroscopic hematuria during an upper respiratory tract infection is common among patients with IgA nephropathy, which suggests a connection between inflammation and disease activity. Interleukin-6 (IL-6) is an inflammatory cytokine involved in IgA immune response. We previously showed that IL-6 selectively increases production of galactose-deficient IgA1 in IgA1-secreting cells from patients with IgA nephropathy. METHODS: We characterized IL-6 signaling pathways involved in the overproduction of galactose-deficient IgA1. To understand molecular mechanisms, IL-6 signaling was analyzed by kinomic activity profiling and Western blotting, followed by confirmation assays using siRNA knock-down and small-molecule inhibitors. RESULTS: STAT3 was differentially activated by IL-6 in IgA1-secreting cells from patients with IgA nephropathy compared with those from healthy control subjects. Specifically, IL-6 induced enhanced and prolonged phosphorylation of STAT3 in the cells from patients with IgA nephropathy, which resulted in overproduction of galactose-deficient IgA1. This IL-6-mediated overproduction of galactose-deficient IgA1 could be blocked by small molecule inhibitors of JAK/STAT signaling. DISCUSSION: Our results revealed that IL-6-induced aberrant activation of STAT3-mediated overproduction of galactose-deficient IgA1. STAT3 signaling pathway may thus represent a new target for disease-specific therapy of IgA nephropathy.
引用
- Yamada K, Huang ZQ, Raska M, et al. Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy. Kidney Int Rep. 2017. PMID: 29270528. doi:10.1016/j.ekir.2017.07.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。